Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients.
Massa F, Cremoni M, Gérard A, Grabsi H, Rogier L, Blois M, Couzin C, Hassen NB, Rouleau M, Barbosa S, Martinuzzi E, Fayada J, Bernard G, Favre G, Hofman P, Esnault VLM, Czerkinsky C, Seitz-Polski B, Glaichenhaus N, Sicard A.
Massa F, et al. Among authors: gerard a.
EBioMedicine. 2021 Nov;73:103679. doi: 10.1016/j.ebiom.2021.103679. Epub 2021 Nov 8.
EBioMedicine. 2021.
PMID: 34763205
Free PMC article.